Rein Therapeutics
RNTX
£1.32
Share price
0.00%
Change (1 day)
-73.19%
Change (1 year)
Categories
EPS for Rein Therapeutics (RNTX)
EPS in 2024 (TTM): -£1.57
According to Rein Therapeutics's latest financial reports the company's current EPS (TTM) is -£1.53. In 2023 the company made an earnings per share (EPS) of -£2.65 an increase over its 2022 EPS that were of -£4.66.
EPS history for Rein Therapeutics from 2015 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -£1.57 | -40.8% |
| 2023 | -£2.65 | -43.19% |
| 2022 | -£4.66 | 2.21% |
| 2021 | -£4.56 | -51.72% |
| 2020 | -£9.44 | -49.17% |
| 2019 | -£18.57 | -43.93% |
| 2018 | -£33.11 | -29.61% |
| 2017 | -£47.04 | 82.33% |
| 2016 | -£25.80 | 40.54% |
| 2015 | -£18.36 |